The United States Food and Drug Administration approved human papillomavirus (HPV) self-collection in a healthcare setting as a cervical cancer screening approach in May 2024. It is therefore important to examine women's acceptability of this approach. We conducted an online survey in September 2024 with a national sample of women ages 45–65 from the United States (n = 296). Logistic regression identified correlates of participants' willingness to use HPV self-collection in a healthcare setting. Overall, 64. 4 percent of participants were willing to use HPV self-collection in a healthcare setting if it was free or covered by insurance, while 23. 9 percent were willing if it cost 150 out of pocket. Participants were more willing to use HPV self-collection for free if they had some form of health insurance (odds ratio OR = 3. 49, 95 percent confidence interval CI: 1. 25–9. 71), had a routine medical checkup within the last year (OR = 3. 50, 95 percent CI: 1. 42–8. 62), or reported a higher perceived likelihood of cervical cancer (OR = 1. 93, 95 percent CI: 1. 18–3. 17). In summary, most women are willing to use HPV self-collection in a healthcare setting if it is free or covered by health insurance. Our findings can guide future programs that include HPV self-collection in a healthcare setting to increase cervical cancer screening.
PURDY et al. (Mon,) studied this question.